tradingkey.logo

NeuroOne Medical Technologies Corp

NMTC
0.780USD
+0.045+6.16%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
39.02MValor de mercado
PerdaP/L TTM

NeuroOne Medical Technologies Corp

0.780
+0.045+6.16%

Mais detalhes de NeuroOne Medical Technologies Corp Empresa

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Informações de NeuroOne Medical Technologies Corp

Código da empresaNMTC
Nome da EmpresaNeuroOne Medical Technologies Corp
Data de listagemNov 09, 2012
CEORosa (David A)
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 09
Endereço7599 Anagram Dr
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344-7399
Telefone19524261383
Sitehttps://nmtc1.com/
Código da empresaNMTC
Data de listagemNov 09, 2012
CEORosa (David A)

Executivos da empresa NeuroOne Medical Technologies Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
816.44K
+200696.00%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.73K
-253.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
201.68K
+64877.00%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
103.08K
-11338.00%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
100.85K
-906.00%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+2.00%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
816.44K
+200696.00%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.73K
-253.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
201.68K
+64877.00%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
103.08K
-11338.00%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
100.85K
-906.00%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+2.00%

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Merchant Adventure Fund LP
8.33%
Bleichroeder LP
7.93%
Sio Capital Management, LLC
4.68%
Bard Associates Inc.
3.67%
The Vanguard Group, Inc.
3.13%
Outro
72.26%
Investidores
Investidores
Proporção
Merchant Adventure Fund LP
8.33%
Bleichroeder LP
7.93%
Sio Capital Management, LLC
4.68%
Bard Associates Inc.
3.67%
The Vanguard Group, Inc.
3.13%
Outro
72.26%
Tipos de investidores
Investidores
Proporção
Investment Advisor
18.33%
Corporation
8.33%
Hedge Fund
6.50%
Individual Investor
4.57%
Investment Advisor/Hedge Fund
3.26%
Research Firm
0.55%
Venture Capital
0.04%
Bank and Trust
0.04%
Outro
58.38%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
51
16.80M
33.31%
-652.40K
2025Q3
51
17.15M
34.30%
+9.56M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
2023Q3
54
7.90M
33.50%
+2.01M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Merchant Adventure Fund LP
4.20M
8.33%
+2.95M
+236.00%
Dec 31, 2024
Bleichroeder LP
4.00M
7.93%
--
--
Sep 30, 2025
Sio Capital Management, LLC
2.36M
4.68%
-1.16M
-33.01%
Sep 30, 2025
Bard Associates Inc.
1.85M
3.67%
-3.60K
-0.19%
Sep 30, 2025
The Vanguard Group, Inc.
1.58M
3.13%
+375.64K
+31.24%
Sep 30, 2025
Perkins Capital Management, Inc.
1.47M
2.91%
-32.00K
-2.13%
Sep 30, 2025
AWM Investment Company, Inc.
916.67K
1.82%
--
--
Sep 30, 2025
Rosa (David A)
613.29K
1.22%
-2.46K
-0.40%
Dec 31, 2025
Renaissance Technologies LLC
692.60K
1.37%
+223.70K
+47.71%
Sep 30, 2025
Geode Capital Management, L.L.C.
496.83K
0.99%
+148.01K
+42.43%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI